The Fish Skin Disease market is estimated to be valued at US$ 1.4 Bn in 2023 and is expected to exhibit a CAGR of 9.8% over the forecast period 2023-2030, as highlighted in a new report published by Coherent Market Insights.

Market Overview:
Fish skin diseases refer to infections, allergies, and other skin conditions that affect fish. Common fish skin diseases include ich, costia, fungus, columnaris, and flukes. Pharmaceutical products used in the treatment of fish skin diseases include creams, lotions, ointments, and medications. These products help to alleviate symptoms, treat underlying infections, and prevent recurrence of skin diseases in fishes kept for commercial and recreational purposes.

Market Dynamics:
The fish skin disease market is expected to witness high growth owing to rising awareness among fish farmers and pet owners regarding fish health and various skin diseases. According to industry sources, approximately 30% of ornamental fish deaths are caused due to untreated skin diseases. This has prompted many to actively seek diagnosis and treatment options. Additionally, increasing consumption of fish and shellfish as a part of the human diet has also boosted research activities related to fish diseases. Further, growing aquaculture production globally is another factor anticipated to contribute to the market growth over the forecast period. The rising global demand for seafood is necessitating sustainable and large scale fish farming practices which require effective disease treatment and management protocols to minimize losses.

Read More -